InspireMD Inc (NSPR)
New Form 8-K - InspireMD, Inc. Filed: 2025-07-31 AccNo: 0001641172-25-021675 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: …
Aoxin Q & M Dental Grp Limited (1D4)
Envoy Medical Inc (COCH)
VistaGen Therapeutics Inc. (VTGN)
Vistagen to Report Fiscal Year 2026 First Quarter Results and Host Corporate Update Conference Call on August 7, 2025
Oragenics Inc. (OGEN)
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial
Mink Therapeutics Inc (INKT)
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report
InspireMD Inc (NSPR)
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
Actinium Pharmaceuticals Inc. (ATNM)
Actinium Presents Data Supporting Paradigm Changing Potential of ATNM-400 in Prostate Cancer Demonstrating Its Superior Efficacy and Improved Survival in Treatment Resistant Tumor Models versus Pluvicto and ARPI Therapy, and Also Enhanced Efficacy in Combination with ARPI Therapy at the 4th Annual Targeted Radiopharmaceuticals Summit
Quoin Pharmaceuticals Ltd DRC (QNRX)
Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025
Myriad Genetics Inc (MYGN)
Myriad Genetics Announces New $200 Million Credit Facility
Neuroone Medical Technologies Corp (NMTC)
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time
GlucoTrack Inc (GCTK)
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
ArgenX Inc (ARGX)
STRATA Skin Sciences Inc (SSKN)
STRATA Skin Sciences to Report Second Quarter 2025 Financial Results on August 13, 2025 and Provide Corporate Update